The Pulse of Profits: Energy, Healthcare, and EVs (e2426)

00:00:00 - Introduction00:00:55 - Oil and Gas Market UpdateOPEC+ meeting impact on oil prices: WTI dropped from $80 to $74, now back to $80Geopolitical risk premium due to Gaza conflict and potential Israel-Hezbollah tensionsNatural gas prices remain low despite heat waveGas production running at 100 bcf/day, down from 104 bcf/day in NovemberNew pipeline from West Texas to Gulf Coast opening in August05:38 - US Government FinancesNeither presidential candidate likely to address need for increased taxes or reduced spendingSocial Security and Medicare trust funds projected to run low in 4-5 yearsBreakdown of federal revenue sources: individual income tax, corporate tax, payroll taxesChallenges in raising additional revenue or cutting major spending categories09:12 - Healthcare Sector UpdateVertex Pharmaceuticals' promising phase 1/2 results for type 1 diabetes treatment11 of 12 patients insulin-independent at 90 days, 3 patients still independent at 1 yearEli Lilly seeking FDA approval for GLP-1 drug to treat sleep apneaGLP-1 drugs on FDA shortage list, allowing compounding pharmacies to produce versionsHims & Hers Health to offer compounded semaglutide, stock rallied on news15:39 - Vertex Pharmaceuticals Deep DiveStrategy of targeting undertreated diseases with smaller patient populationsContinuous improvement in cystic fibrosis treatmentsPipeline includes treatments for kidney disease, pain, and type 1 diabetesNon-opioid pain medication in phase 3 trials with potential for nerve pain treatmentAcquisition strategy combining technologies (e.g. stem cells and encapsulation for diabetes)21:15 - Tesla and EV Market AnalysisBreaking down Tesla's valuation between automotive business and other venturesMorgan Stanley price target of $310/share, only $105 attributed to automotiveOther potential value drivers: full self-driving/robotaxi service, humanoid robotsChallenges in EV market: higher interest rates, increased competitionComparison to Apple's ecosystem and customer loyaltyChinese competition in low-cost EV production29:21 - Wrap-up and Next Week's PreviewThis podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com